供者来源血小板制品用于止血治疗的过去与当前进展
本综述总结了近期关于替代性供者来源血小板制品的临床前与临床研究,涵盖冷藏、冷冻、冻干血小板及全血等策略。室温储存血小板5至7天的规定受到近期临床试验数据、输血传播感染及 shortages 的挑战,替代储存方法可延长储存时间或改善止血潜力。
要点
- 冷藏血小板可延长储存时间并改善止血潜力,但循环时间缩短。
- 冷冻血小板可储存数年,需-80°C保存及输注前解冻。
- 冻干血小板可室温粉末储存数年,数分钟内无菌水重建,但研究最少。
核心结论
- 替代性供者来源血小板制品(冷藏、冷冻、冻干及全血)的体外特性认识不断深入,临床试验数据正在积累。
研究设计与样本
- 综述,总结近期关于替代性供者来源血小板制品的临床前与临床研究。
主要发现
- 冷藏血小板可能延长储存时间(数天)并改善止血潜力,但循环时间缩短。
- 冷冻(冷冻保存)血小板可将储存时间延长至数年,但需-80°C保存及输注前解冻。
- 冻干血小板可室温粉末储存数年,数分钟内无菌水重建,但可能是目前研究最少的替代血小板制品。
- 全血提供所有血液成分的止血谱,但存在ABO不相容等挑战。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
More than 100 years ago, Duke transfused whole blood to a patient with thrombocytopenia to raise the platelet count and prevent bleeding. Since then, platelet transfusions have undergone numerous modifications from whole blood-derived platelet-rich plasma to apheresis-derived platelet concentrates. The storage time and temperature have also changed. The mandate to store platelets for a maximum of 5 to 7 days at room temperature has been challenged by recent clinical trial data, ongoing difficulties with transfusion-transmitted infections, and recurring periods of shortages that were further exacerbated by the COVID-19 pandemic. Alternative platelet storage approaches are as old as the first platelet transfusions. Cold-stored platelets may offer increased storage times (days) and improved hemostatic potential at the expense of reduced circulation time. Frozen (cryopreserved) platelets extend the storage time to years but require storage at -80°C and thawing before transfusion. Lyophilized platelets can be powder-stored for years at room temperature and reconstituted within minutes in sterile water but are probably the least explored alternative platelet product to date. Finally, whole blood offers the hemostatic spectrum of all blood components but has challenges such as ABO incompatibility. We know more than ever before about the in vitro properties of these products, and clinical trial data are accumulating. The purpose of this review is to summarize the findings of recent preclinical and clinical studies on alternative, donor-derived platelet products.
引用
- Kogler VJ, Stolla M. There and back again: the once and current developments in donor-derived platelet products for hemostatic therapy. Blood. 2022. PMID: 35482959. doi:10.1182/blood.2021014889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。